DN
Deepti Niranjan Dandekar
About Deepti Niranjan Dandekar
Data last updated:
Deepti Niranjan Dandekar is a Director at Nikash Remedies Private Limited (since 2023), Designated Partner at Eds Research Llp (since 2025) and Designated Partner at Evolvus Informatics Llp (since 2025). The companies operate in Information Technology. The largest current company by reported revenue is Nikash Remedies Private Limited at ₹4.8 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Mar 2023 | 2023 | ₹4.8 Lakh (FY 2024) | Active | |
| Designated Partner | 27 May 2025 | 2025 | Active | ||
| Designated Partner | 30 Apr 2025 | 2016 | Active |
Board colleagues of Deepti Niranjan Dandekar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Alok Dileep Deodhar | 08887604 | Nikash Remedies Private Limited , Eds Research Llp | Director |
| Sulaxana Alok Deodhar | 10333000 | Eds Research Llp | Designated Partner |
| Archana Chintamani Hajare | 11046812 | Evolvus Informatics Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Deepti Niranjan Dandekar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deepti Niranjan Dandekar
Deepti Niranjan Dandekar currently holds 3 directorships: Nikash Remedies Private Limited (Director, since 29 Mar 2023, revenue ₹4.8 Lakh (FY 2024)); Eds Research Llp (Designated Partner, since 27 May 2025); Evolvus Informatics Llp (Designated Partner, since 30 Apr 2025).
Deepti Niranjan Dandekar was first appointed on 29 Mar 2023 as Director at Nikash Remedies Private Limited. The most recent appointment on record is 27 May 2025 at Eds Research Llp.
The current boards of Deepti Niranjan Dandekar's companies include Alok Dileep Deodhar (Nikash Remedies Private Limited), Sulaxana Alok Deodhar (Eds Research Llp), Archana Chintamani Hajare (Evolvus Informatics Llp).